// Index Comparison
ACCE Quality Compounders vs ACCE Semiconductors
Head-to-head: performance, risk profile, and constituent overlap between two ACCE indices.
US
ACCE Quality Compounders →
High-ROIC, wide-moat businesses compounding shareholder value through pricing power, network effects, and recurring revenue.
US
ACCE Semiconductors →
The full semiconductor value chain — from chip design through fabrication to equipment. Cyclical upswing meets structural AI demand.
ACCE Quality Compounders — risk
Volatility 30d+24.4%
Volatility 90d+23.5%
Sharpe 90d-2.08
Max drawdown-22.8%
Beta vs SPY0.56
ACCE Semiconductors — risk
Volatility 30d+39.1%
Volatility 90d+36.9%
Sharpe 90d2.59
Max drawdown-13.9%
Beta vs SOXX2.09
Constituent overlap
0 stocks held by both indices (out of 6 and 11)
Top sectors — ACCE Quality Compounders
Technology35.4%
Financial Services29.9%
Consumer Defensive19.4%
Healthcare15.4%
Top sectors — ACCE Semiconductors
Technology100.0%
ACCE Verdict
ACCE Semiconductors has crushed ACCE Quality Compounders since inception, delivering 33.28% returns versus a brutal -13.67% loss for the quality-focused index. The semiconductor index's 2.59 Sharpe ratio demolishes Quality Compounders' -2.08, despite semiconductors carrying significantly higher volatility at 37% versus 23%.
These indices occupy opposite ends of the risk spectrum, with semiconductors running a 2.09 beta compared to Quality Compounders' defensive 0.56 positioning. While both target structural growth themes, semiconductors rides the AI wave with cyclical leverage, whereas Quality Compounders seeks steady compounding through moats and pricing power.
**Verdict:** Semiconductors suits aggressive growth investors willing to stomach 37% volatility for explosive upside potential, especially those betting on continued AI infrastructure buildout. Quality Compounders appeals to defensive value investors seeking lower-beta exposure to proven business models, though current performance suggests either poor timing or flawed execution of the quality thesis. Risk-tolerant investors should favor semiconductors' momentum, while conservative portfolios might wait for Quality Compounders to prove its defensive qualities actually work.